IMC Chicago’s 10x Genomics TXG Stock Holding History

IMC Chicago’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Sell	10,000 -6,300	-39%	-$126K	﹤0.01%	4953
2025 Q4	$266K	Buy	+16,300	New	+$246K	﹤0.01%	3872

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's TXG Position: Q1 2026 in Review

IMC Chicago increased its 10x Genomics (TXG) stake by 57% in Q1 2026, buying an estimated $182K and bringing the position to 25,257 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

IMC Chicago first reported a position in TXG in Q4 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

IMC Chicago held 25,257 shares of 10x Genomics worth $536K as of Q1 2026.
IMC Chicago bought 9,123 10x Genomics shares in Q1 2026, an estimated $182K.
10x Genomics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3969 holding.
IMC Chicago first reported a position in 10x Genomics in Q4 2025 and has held it in 2 quarters since.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.